Over the last 180 days, Oncotelic Therapeutics, Inc. insiders bought a net $38.5K of stock across 25 Form 4 purchases and sales, with 2 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.
Showing the most recent few. Create a free account to see 20 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
no 13F holders found for this ticker
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | — | — | $70.0K | — |
| OPERATING INCOME | $-3.2M | $-3.6M | $-6.6M | $-9.7M |
| NET INCOME | $249.3M | $-4.5M | $-7.9M | $5.1M |
| EPS (DILUTED) | 0.59 | -0.01 | -0.02 | 0.01 |
| OPERATING CASH FLOW | $-1.4M | $-740.3K | $-1.3M | $-1.5M |
| CASH | — | — | $170.4K | $241.5K |
No password to create and no card required. We store your email address and nothing else.